Cadavedo, Ian Rose .
HRN: 14-28-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CEFUROXIME 1.5GM (VIAL)
09/20/2022
09/20/2022
IVT
1.5g
Loading Dose
CS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes